BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29676232)

  • 1. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
    Peedicayil J
    Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
    Lopomo A; Coppedè F
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):49-62. PubMed ID: 28856927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
    Griñán-Ferré C; Bellver-Sanchis A; Guerrero A; Pallàs M
    Pharmacol Res; 2024 Jun; 205():107247. PubMed ID: 38834164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs.
    Baer-Dubowska W; Majchrzak-Celińska A; Cichocki M
    Pharmacol Rep; 2011; 63(2):293-304. PubMed ID: 21602587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
    Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promises and challenges in pharmacoepigenetics.
    Smith DA; Sadler MC; Altman RB
    Camb Prism Precis Med; 2023; 1():e18. PubMed ID: 37560024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomics and interindividual differences in drug response.
    Ivanov M; Kacevska M; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2012 Dec; 92(6):727-36. PubMed ID: 23093317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis and treatment response in complex diseases.
    Banerjee M
    Pharmacogenomics; 2022 Jan; 23(2):81-84. PubMed ID: 34842441
    [No Abstract]   [Full Text] [Related]  

  • 10. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepigenetics and pharmacoepigenomics.
    Peedicayil J
    Pharmacogenomics; 2008 Dec; 9(12):1785-6. PubMed ID: 19072635
    [No Abstract]   [Full Text] [Related]  

  • 12. Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics.
    Cascorbi I
    Pharmacogenomics; 2013 Nov; 14(15):1807-9. PubMed ID: 24236479
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response.
    Cacabelos R; Torrellas C
    Int J Mol Sci; 2015 Dec; 16(12):30483-543. PubMed ID: 26703582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
    Ling C
    Diabetologia; 2022 Nov; 65(11):1849-1853. PubMed ID: 35307762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics primer: why the clinician should care about epigenetics.
    Duarte JD
    Pharmacotherapy; 2013 Dec; 33(12):1362-8. PubMed ID: 23864439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and pharmacoepigenomics in pediatric medicine.
    Shastry BS
    Methods Mol Biol; 2014; 1175():671-85. PubMed ID: 25150880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics in the treatment of systemic lupus erythematosus: potential clinical application.
    Guo Y; Sawalha AH; Lu Q
    Clin Immunol; 2014 Nov; 155(1):79-90. PubMed ID: 25218424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic changes in gene expression for drug-metabolizing enzymes and transporters.
    Kim IW; Han N; Burckart GJ; Oh JM
    Pharmacotherapy; 2014 Feb; 34(2):140-50. PubMed ID: 24166985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms of importance for drug treatment.
    Ivanov M; Barragan I; Ingelman-Sundberg M
    Trends Pharmacol Sci; 2014 Aug; 35(8):384-96. PubMed ID: 24993164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.